CLB NYSE
Core Laboratories N.V.
1W: +7.8%
1M: -14.9%
3M: -21.2%
YTD: -14.3%
1Y: +27.0%
3Y: -28.9%
5Y: -56.8%
$14.22
-0.28 (-1.93%)
Weekly Expected Move ±9.2%
$11
$12
$13
$14
$15
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$527M
+0.5% ▲
5Y CAGR: +1.6%
Gross Profit
$94M
+6.7% ▲
5Y CAGR: -1.6%
Operating Income
$49M
-16.6% ▼
Net Income
$32M
+1.3% ▲
EPS (Diluted)
$0.68
+3.0% ▲
EBITDA
$64M
-13.3% ▼
5Y CAGR: -2.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $470M | $490M | $510M | $524M | $527M |
| YoY Growth | -3.5% | +4.1% | +4.1% | +2.8% | +0.5% |
| Cost of Revenue | $386M | $411M | $416M | $435M | $432M |
| Gross Profit | $84M | $79M | $94M | $88M | $94M |
| Gross Margin | 17.8% | 16.1% | 18.4% | 16.9% | 17.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $44M | $38M | $39M | $39M | $45M |
| Operating Expenses | $39M | $37M | $39M | $30M | $45M |
| Operating Income | $45M | $42M | $55M | $59M | $49M |
| Operating Margin | 9.6% | 8.5% | 10.7% | 11.2% | 9.3% |
| Interest Expense | $9M | $12M | $13M | $12M | $10M |
| Income Before Tax | $36M | $30M | $41M | $46M | $46M |
| Tax Expense | $16M | $10M | $4M | $14M | $13M |
| Net Income | $20M | $19M | $37M | $31M | $32M |
| Net Margin | 4.2% | 4.0% | 7.2% | 6.0% | 6.0% |
| EPS (Diluted) | $0.42 | $0.42 | $0.77 | $0.66 | $0.68 |
| EBITDA | $64M | $59M | $70M | $73M | $64M |
| Shares Outstanding | 47M | 47M | 48M | 48M | 46M |